Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V T DeVita

Showing results (1-10 of 268) with videos related to

Pageof 27
Sort By:
Public Health Reports (Washington, D.C. : 1974)|January 1, 1986
Lung cancer rates are alarming and are NCI's greatest challengeV T DeVita
Cancer Research|December 1, 1983
Governance of science at the national cancer institute: management of resources in an era of scarcityV T DeVita
Cancer|April 1, 1983
The James Ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancerV T DeVita
Annals of Internal Medicine|August 1, 1991
On clinical alertsV T DeVita
Current Opinion in Oncology|November 5, 1997
Late sequelae of treatment of Hodgkin's diseaseV T DeVita
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
The war on cancer has a birthday, and a presentV T DeVita
The New England Journal of Medicine|April 20, 1978
The evolution of therapeutic research in cancerV T DeVita
Cancer Research|August 1, 1983
The governance of science at the National Cancer Institute: a perspective on misperceptionsV T DeVita
International Journal of Radiation Oncology, Biology, Physics|June 1, 1979
The role of combined modality therapy in the treatment of stage IIIA Hodgkin's diseaseV T DeVita
Hospital Practice (Office Ed.)|September 15, 1986
Hematologic malignancies: non-Hodgkin's lymphomasV T DeVita
Pageof 27

Showing results (1-10 of 268) with videos related to

Sort By:
Pageof 27
Public Health Reports (Washington, D.C. : 1974)|January 1, 1986
Lung cancer rates are alarming and are NCI's greatest challengeV T DeVita
Cancer Research|December 1, 1983
Governance of science at the national cancer institute: management of resources in an era of scarcityV T DeVita
Cancer|April 1, 1983
The James Ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancerV T DeVita
Annals of Internal Medicine|August 1, 1991
On clinical alertsV T DeVita
Current Opinion in Oncology|November 5, 1997
Late sequelae of treatment of Hodgkin's diseaseV T DeVita
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
The war on cancer has a birthday, and a presentV T DeVita
The New England Journal of Medicine|April 20, 1978
The evolution of therapeutic research in cancerV T DeVita
Cancer Research|August 1, 1983
The governance of science at the National Cancer Institute: a perspective on misperceptionsV T DeVita
International Journal of Radiation Oncology, Biology, Physics|June 1, 1979
The role of combined modality therapy in the treatment of stage IIIA Hodgkin's diseaseV T DeVita
Hospital Practice (Office Ed.)|September 15, 1986
Hematologic malignancies: non-Hodgkin's lymphomasV T DeVita
Pageof 27